ArticleHematology reports2023

Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment.

Jesse Fishman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.